Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 23, 2023
0Patent Application Number
178214260
Date Filed
August 22, 2022
0Patent Citations
...
Patent Citations Received
Patent Primary Examiner
Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab, and their use in the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.